Biodesix Inc. (BDSX) is a diagnostic company focused on lung disease. The company develops and commercializes diagnostic tests for lung cancer and other pulmonary conditions, serving providers, payers, patients, and biopharmaceutical companies. Its products support clinical decision-making and it also provides services to biopharmaceutical companies. Biodesix operates in the U.S. and seeks reimbursement coverage from insurance payers for its diagnostic tests.
Q2 FY2026 — expected 2026-09-13
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-26 | 2025-12-31 | 0001193125-26-076547 | EDGAR | 95K words |
| 2025-03-03 | 2024-12-31 | 0000950170-25-030835 | EDGAR | — |
| 2024-03-01 | 2023-12-31 | 0000950170-24-023513 | EDGAR | — |
| 2023-03-06 | 2022-12-31 | 0000950170-23-006092 | EDGAR | — |
| 2022-03-14 | 2021-12-31 | 0000950170-22-003495 | EDGAR | — |
| 2021-03-16 | 2020-12-31 | 0001564590-21-013512 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-05 | 2026-06-30 | 0001193125-26-335036 | EDGAR | — |
| 2025-11-03 | 2025-09-30 | 0001193125-25-262532 | EDGAR | 33K words |
| 2025-08-07 | 2025-06-30 | 0000950170-25-105026 | EDGAR | — |
| 2025-05-13 | 2025-03-31 | 0000950170-25-070339 | EDGAR | — |
| 2024-11-01 | 2024-09-30 | 0000950170-24-119792 | EDGAR | — |
| 2024-08-07 | 2024-06-30 | 0000950170-24-092773 | EDGAR | — |
| 2024-05-08 | 2024-03-31 | 0000950170-24-055651 | EDGAR | — |
| 2023-11-07 | 2023-09-30 | 0000950170-23-060226 | EDGAR | — |
| 2023-08-07 | 2023-06-30 | 0000950170-23-039073 | EDGAR | — |
| 2023-05-11 | 2023-03-31 | 0000950170-23-021238 | EDGAR | — |
| 2022-11-03 | 2022-09-30 | 0000950170-22-021488 | EDGAR | — |
| 2022-08-04 | 2022-06-30 | 0000950170-22-014433 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-05 | 0001193125-26-335010 | EDGAR | — |
| 2026-02-26 | 0001193125-26-076521 | EDGAR | 3K words |
| 2025-11-03 | 0001193125-25-262508 | EDGAR | — |
| 2025-10-01 | 0001193125-25-226749 | EDGAR | — |
| 2025-09-15 | 0001193125-25-203746 | EDGAR | — |
| 2025-09-11 | 0001193125-25-200766 | EDGAR | — |
| 2025-08-07 | 0001439725-25-000003 | EDGAR | — |
| 2025-05-21 | 0001193125-25-124047 | EDGAR | — |
| 2025-05-13 | 0000950170-25-070292 | EDGAR | — |
| 2025-04-17 | 0001193125-25-084319 | EDGAR | — |
101 total filings indexed. 73 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001439725 |
| Ticker | BDSX |
| Exchange | Nasdaq |
| SIC | 8071: Services-Medical Laboratories |
| Incorporated | DE |
| Website | https://www.biodesix.com |
| Listed | 2020-10-28 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/BDSX (~200 tokens, structured JSON with cryptographic provenance)